Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting-Reference-Cited by-同舟云学术

Adverse Events in Patients With Rheumatoid Arthritis and Psoriatic Arthritis Receiving Long-Term Biological Agents in a Real-Life Setting

Published:2019-09-11 Issue: Volume:10 Page:
ISSN:1663-9812
Container-title:Frontiers in Pharmacology
language:
Short-container-title:Front. Pharmacol.

Author:

de Camargo Mayara Costa,Barros Bruna Cipriano Almeida,Fulone Izabela,Silva Marcus Tolentino,Silveira Miriam Sanches do Nascimento,Camargo Iara Alves de,Barberato-Filho Silvio,Del Fiol Fernando de Sá,Lopes Luciane Cruz

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Publisher

Frontiers Media SA

Subject

Pharmacology (medical),Pharmacology

Reference72 articles.

1. Portaria n°. 66, de 6 de novembro de 2006. Health Tecnology and Strategy Drugs Secretariat. Clinical Protocol and Guidelines- Rheumatoid Arthrist Diário Oficial da União2006

2. Artrite Psoriática. Protocolo Clínico e Diretrizes Terapêuticas. Portaria SAS/MS n° 1.204, de 4 de novembro de 20142014

3. Canadian Rheumatology Association recommendations for pharmacological management of rheumatoid arthritis with traditional and biologic disease-modifying antirheumatic drugs;Bykerk;J. Rheumatol.,2012

4. Gap between official guidelines and clinical practice for the treatment of rheumatoid arthritis in São Paulo, Brazil;Camargo;Clin. Ther.,2016

5. A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness;Chen;Health Technol. Assess.,2006

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Phytochemical Formulations for Management of Rheumatoid Arthritis: A Review;Current Drug Delivery;2025-01

2. Designing biomaterials for the treatment of autoimmune diseases;Applied Materials Today;2024-08

3. Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiative;Journal of Managed Care & Specialty Pharmacy;2024-07

4. Cutaneous immune-related phenomena in patients with inflammatory arthritides treated with biological therapies: Clinical and pathophysiological considerations;Seminars in Arthritis and Rheumatism;2023-12

5. Challenges in the Management of Psoriatic Arthritis in Latin America: A Systematic Review;Clinical Therapeutics;2023-09